A novel homozygous mutation in ATP13A2 gene causing pure hereditary spastic paraplegia
- 1 May 2021
- journal article
- letter
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 86, 58-60
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 6 references indexed in Scilit:
- Intermediate phenotype of ATP13A2 mutation in two Chilean siblings: Towards a continuum between parkinsonism and hereditary spastic paraplegiaParkinsonism & Related Disorders, 2020
- Identification of a novel mutation in ATP13A2 associated with a complicated form of hereditary spastic paraplegiaNeurology Genetics, 2020
- From PARK9 to SPG78: The clinical spectrum of ATP13A2 mutationsParkinsonism & Related Disorders, 2019
- Loss-of-function mutations in theATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)Brain, 2017
- Genetic and phenotypic characterization of complex hereditary spastic paraplegiaBrain, 2016
- Common Pathogenic Effects of Missense Mutations in the P-Type ATPase ATP13A2 (PARK9) Associated with Early-Onset ParkinsonismPLOS ONE, 2012